INTRODUCTION
Intracystic papillary carcinoma (IPC) of the breast is a rare entity, known to be accounting for between 0.5% and 1% of all breast cancers.(1,2) Papillary lesions in the breast have a wide spectrum of lesions that include benign papilloma, papillary variants of ductal carcinoma in situ (DCIS), and invasive papillary carcinoma. Traditionally, IPC was considered to be a variant of DCIS, as a localized form of intraductal papillary carcinoma that exists in a cystically dilated duct. (2) Although it has been believed that IPC may exist as an isolated localized non-invasive carcinoma, being associated with DCIS or with invasive carcinoma,(3) recent studies have suggested that IPC should be considered as a low risk invasive carcinoma. (4) We tried to find out the data of IPC of Korean women, but only five reports of a single case could be found through the web-based search of KoreaMed (http://www. koreamed.org) and the first report was in 1997 with a case of 80-yr-old female breast cancer. (5) (6) (7) (8) (9) This small amount of work which has been done in Korea may be due to a rarity of IPC in Korean women, but this also may be due to lack of clinical interests for IPC since it was mistaken as a variant of DCIS which has a good prognosis after treatment, resulting in rough discrimination between IPC and DCIS. Given that IPC is considered a low risk invasive carcinoma, this should be reevaluated as an independent disease entity other than DCIS. After review of the 14-yr surgical and pathological database of a single institute, we could find only four cases of IPC among 7,109 cases who underwent surgery for breast cancer. Thus, we report these cases with a review of the recent literature.
Intracystic papillary carcinoma (IPC) of the breast is a rare entity, which can be associated with ductal carcinoma in situ (DCIS) or an invasive carcinoma. There have been only limited reports describing IPC in Korea and the incidence among breast cancer cases in Korea has not yet been reported. From a database of 7,109 breast cancer cases treated surgically at Samsung Medical Center, we could only identify four IPC cases (0.056%). We also found that there are some differences between the clinicopathological characteristics of our cases and the alleged characteristics of IPC as reported from Western countries, such as a relatively young age of onset, small tumor size and various expression levels of hormonal receptors. We suspect this very low incidence may be caused by a true rarity of IPC in women in Korea or may be due to a lack of clinical interest for IPC. Upon presentation of our experience with IPC, we suggest the diagnosis for this rare disease entity needs to be reappraised. Figure   2B ). MECs were not found in the core of the papillae and rarely observed at the periphery of the tumor nodules.
Associated DCIS was found in only one case, and in the other three cases, there was no DCIS or invasive component observed around the IPC lesion.
Tamoxifen was prescribed in two patients who had a strong ER and PR positivity with immunohistochemistry examination. One of these patients was diagnosed as IPC in contralateral breast despite of 2-yr tamoxifen treatment due to previously diagnosed DCIS. The other two patients were ER-and PR-negative so that tamoxifen was not prescribed. Adjuvant chemotherapy was not indicated for all these patients (Table 3) . Although the follow- We could find some differences between the characteristics of our cases, such as the relatively early age of onset especially in two patients and small sizes of tumor, and the previously known features of IPC (Table 1) From the review of this small number of IPC cases, we suggest that the diagnosis of IPC needs to be reappraised in Korea, considering it has some characteristics between in situ and invasive papillary carcinoma. Although the incidence of IPC was very low among the breast cancer patients who were treated in our institute, it may be influenced by the lack of diagnostic interest for IPC. The incidence of IPC in Korean women needs to be further evaluated through a multicenter study with a pathologic standard for its diagnosis.
